Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Active, Not Recruiting

A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

NCT07266090

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • The First Affiliated Hospital Of Jinan University Guangzhou, Guangdong, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

NCT04877691

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Paradise Valley, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site El Cajon, California, United States
View all 140 locations
View Trial Details
Active, Not Recruiting

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

NCT05531565

Conditions
Autoimmune Diseases, Chronic Cutaneous Lupus Erythematosus, Connective Tissue Diseases, +7 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • UAB Center for Women's Reproductive Health Birmingham, Alabama, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Phoenix, Arizona, United States
  • The Regents of the University of California La Jolla, California, United States
View all 315 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

NCT05639114

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group Llc Anniston, Alabama, United States
  • Providence Medical Center Burbank, California, United States
  • University of California San Diego La Jolla, California, United States
  • Millennium Clinical Trials Westlake Village, California, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

NCT05624749

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California LA Los Angeles, California, United States
  • Homestead Assoc In Research Inc Homestead, Florida, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

NCT05798117

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Pessac, France
  • Novartis Investigative Site Strasbourg, France
View Trial Details
Active, Not Recruiting

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

NCT06799520

Conditions
Alopecia, Alopecia Areata, Alopecia Areata (AA), +10 more
Locations
  • Visterra Investigational Site Sofia, Bulgaria
  • Visterra Investigational Site Chisinau, Moldova
  • Visterra Investigational Site Bucharest, Romania
  • Visterra Investigational Site Cluj-Napoca, Romania
View Trial Details
Active, Not Recruiting

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

NCT05966480

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Investigator Site #1046 Anniston, Alabama, United States
  • Investigator Site #1104 La Jolla, California, United States
  • Investigator Site #1050 Los Alamitos, California, United States
  • Investigator Site #1168 Mission Hills, California, United States
View all 169 locations
View Trial Details
Active, Not Recruiting

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

NCT05540327

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • The Lundquist Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • Bay Area Arthritis and Osteoporosis Brandon, Florida, United States
  • Advance Medical Research Center Miami, Florida, United States
  • Dawes Fretzin Dermatology Group, LLC Indianapolis, Indiana, United States
View all 122 locations
View Trial Details

Related conditions